CLC number:
On-line Access: 2021-12-14
Received: 2021-06-03
Revision Accepted: 2021-09-17
Crosschecked: 0000-00-00
Cited: 0
Clicked: 1741
Peiwen ZHANG, Dandan XU, Xinhan ZHANG, Mengyin WU, Xuecheng YAO, Dawei CUI, Jue XIE. Factors associated with red blood cell transfusion among hospitalized patients: a cross-sectional study[J]. Journal of Zhejiang University Science B, 2021, 22(12): 1060-1064.
@article{title="Factors associated with red blood cell transfusion among hospitalized patients: a cross-sectional study",
author="Peiwen ZHANG, Dandan XU, Xinhan ZHANG, Mengyin WU, Xuecheng YAO, Dawei CUI, Jue XIE",
journal="Journal of Zhejiang University Science B",
volume="22",
number="12",
pages="1060-1064",
year="2021",
publisher="Zhejiang University Press & Springer",
doi="10.1631/jzus.B2100491"
}
%0 Journal Article
%T Factors associated with red blood cell transfusion among hospitalized patients: a cross-sectional study
%A Peiwen ZHANG
%A Dandan XU
%A Xinhan ZHANG
%A Mengyin WU
%A Xuecheng YAO
%A Dawei CUI
%A Jue XIE
%J Journal of Zhejiang University SCIENCE B
%V 22
%N 12
%P 1060-1064
%@ 1673-1581
%D 2021
%I Zhejiang University Press & Springer
%DOI 10.1631/jzus.B2100491
TY - JOUR
T1 - Factors associated with red blood cell transfusion among hospitalized patients: a cross-sectional study
A1 - Peiwen ZHANG
A1 - Dandan XU
A1 - Xinhan ZHANG
A1 - Mengyin WU
A1 - Xuecheng YAO
A1 - Dawei CUI
A1 - Jue XIE
J0 - Journal of Zhejiang University Science B
VL - 22
IS - 12
SP - 1060
EP - 1064
%@ 1673-1581
Y1 - 2021
PB - Zhejiang University Press & Springer
ER -
DOI - 10.1631/jzus.B2100491
Abstract: red blood cell (RBC) transfusion is a clinically effective therapy in anemia, for example in patients with malignancies (Shander et al., 2020), bleeding (Odutayo et al., 2017), and preoperative anemia (Padmanabhan et al., 2019). The past few decades have witnessed a shortage of blood for transfusion due to limited health insurance coverage for blood use and the rapid expansion of hospitals (Chen et al., 2011; Shi et al., 2014). Blood donation levels may easily be affected by general changes in the environment, policy, major events such as disasters, and public sentiment (Hu et al., 2019). Meanwhile, the transfusion of allogeneic RBC is a double-edged sword, increasing the possibility of infectious and immunological complications, and also leading to higher morbidity and mortality after transfusion (Frank et al., 2012). Considering that the continual shortfall has been increasingly prominent, identifying the factors associated with RBC transfusion could help blood transfusion departments to improve their supply of blood products as well as their inventory management (O'Donnell et al., 2018).
[1]ChenXF, ChenCL, ZhangY, et al., 2011. The effect of health insurance reform on the number of cataract surgeries in Chongqing, China. BMC Health Serv Res, 11:67.
[2]FrankSM, SavageWJ, RothschildJA, et al., 2012. Variability in blood and blood component utilization as assessed by an anesthesia information management system. Anesthesiology, 117(1):99-106.
[3]HuW, MengHD, HuQY, et al., 2019. Blood donation from 2006 to 2015 in Zhejiang Province, China: annual consecutive cross-sectional studies. BMJ Open, 9:e023514.http://dx.doi.org/10.1136/bmjopen-2018-023514
[4]O'DonnellTFX, SheanKE, DeerySE, et al., 2018. A preoperative risk score for transfusion in infrarenal endovascular aneurysm repair to avoid type and cross. J Vasc Surg, 67(2):442-48.
[5]Odutayo, A, DesboroughMJR, TrivellaM, et al., 2017. Restrictive versus liberal blood transfusion for gastrointestinal bleeding: a systematic review and meta-analysis of randomised controlled trials. Lancet Gastroenterol Hepatol, 2(5):354-360.
[6]PadmanabhanH, BrookesMJ, NevillAM, et al., 2019. Association between anemia and blood transfusion with long-term mortality after cardiac surgery. Ann Thorac Surg, 108(3):687-692.
[7]ShanderA, KaulfmanM, GoognoughLT, 2020. How I treat anemia in the perisurgical setting. Blood, 136(7):814-822.
[8]ShiL, WangJX, StevensL, et al., 2014. Blood safety and availability: continuing challenges in China’s blood banking system. Transfusion, 54(2):471-482.
[9]XiangWL, ChengJJ, WuLP, et al., 2020. Clinical character
[10]istics and plasma antibody titer of patients with COVID-19 in Zhejiang, China. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 21(12):955-960.
[11]informationSupplementary
[12]Materials and methods; TablesS1‒S3; Fig. S1
Open peer comments: Debate/Discuss/Question/Opinion
<1>